Live Breaking News & Updates on Surface Ophthalmics

Stay updated with breaking news from Surface ophthalmics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Harrow, Inc. (NASDAQ:HROW) Short Interest Down 9.5% in May

Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 4,980,000 shares, a decline of 9.5% from the April 30th total of 5,500,000 shares. Based on an average daily volume of 510,400 shares, the […] ....

Markl-baum , Craig-hallum , Pricet-rowe-associates-inc , Surface-ophthalmics-inc , Pharmaceuticals-inc , Nasdaq , Opaleye-management-inc , Harrow-inc , Vanguard-group-inc , Harrow-health-inc , Eton-pharmaceuticals-inc , Get-free-report

Harrow (NASDAQ:HROW) Shares Down 5.8%

Shares of Harrow, Inc. (NASDAQ:HROW – Get Free Report) traded down 5.8% on Wednesday . The company traded as low as $17.45 and last traded at $17.49. 215,167 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 464,695 shares. The stock had previously closed at $18.56. Analyst Upgrades […] ....

China , Craig-hallum , Markl-baum , Jump-financial , Nasdaq , Securities-exchange-commission , Opaleye-management-inc , Kennedy-capital-management , Harrow-company-profile , Stifel-financial-corp , China-universal-asset-management-co , Surface-ophthalmics-inc

Analysts Offer Predictions for Harrow, Inc.'s Q2 2024 Earnings (NASDAQ:HROW)

Harrow, Inc. (NASDAQ:HROW – Free Report) – B. Riley dropped their Q2 2024 earnings per share (EPS) estimates for Harrow in a research report issued to clients and investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now expects that the company will earn ($0.25) per share for the quarter, down from their previous […] ....

Markl-baum , Craig-hallum , Jump-financial , Harrow-health-inc , Nasdaq , Rice-hall-james-associates , Harrow-inc , Securities-exchange-commission , Kennedy-capital-management , Stifel-financial-corp , Pharmaceuticals-inc , Eton-pharmaceuticals-inc

Harrow, Inc. (NASDAQ:HROW) Short Interest Update

Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 30th, there was short interest totalling 5,500,000 shares, a decrease of 7.1% from the April 15th total of 5,920,000 shares. Based on an average daily trading volume, of 462,100 shares, the days-to-cover ratio […] ....

Craig-hallum , Markl-baum , Surface-ophthalmics-inc , Harrow-inc , Ophir-asset-management-pty-ltd , Harrow-company-profile , Harrow-health-inc , Eton-pharmaceuticals-inc , Opaleye-management-inc , Securities-exchange-commission , Nasdaq , Pharmaceuticals-inc

Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […] ....

Craig-hallum , Institutional-trading-of-harrow-health , Eton-pharmaceuticals-inc , Harrow-health , Envestnet-asset-management-inc , Surface-ophthalmics-inc , Securities-exchange-commission , Nasdaq , Wasatch-advisors-inc , Opaleye-management-inc , Harrow-health-inc , Prelude-capital-management